A Federal Judge In Manhattan Ruled For Novartis On Wednesday Against Allegations That It Misused One Of Its Patents To Maintain Its Exclusivity On Its Blockbuster Heart-Failure Drug Entresto

A federal judge in Manhattan ruled in favor of Novartis regarding allegations that the company misused a patent to sustain exclusivity for its heart-failure drug, Entresto. This ruling is significant for Novartis as it helps maintain the market position of this blockbuster drug. The stock ticker for Novartis is NVS.